Globeimmune - 53 Year Dividend History | GBIM
Historical dividend payout and yield for Globeimmune (GBIM) since 1972. The current TTM dividend payout for Globeimmune (GBIM) as of August 21, 2025 is $0.00. The current dividend yield for Globeimmune as of August 21, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
GlobeImmune, Inc. is a biopharmaceutical company. It is focused on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen (R) platform. The Company's products under development includes GI-5005, a product for the treatment of chronic hepatitis C infection; and GI-4000 for pancreas, non-small cell lung, colorectal, and other cancers. GlobeImmune, Inc. is based in Louisville, Colorado.
|
